BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18084253)

  • 21. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma.
    Wang Y; Liu S; Zhu H; Zhang W; Zhang G; Zhou X; Zhou C; Quan L; Bai J; Xue L; Lu N; Xu N
    Int J Cancer; 2008 Aug; 123(3):561-8. PubMed ID: 18498136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma.
    Song Y; Li J; Zhu Y; Dai Y; Zeng T; Liu L; Li J; Wang H; Qin Y; Zeng M; Guan XY; Li Y
    Oncotarget; 2014 Nov; 5(22):11669-80. PubMed ID: 25375090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FH535 increases the radiosensitivity and reverses epithelial-to-mesenchymal transition of radioresistant esophageal cancer cell line KYSE-150R.
    Su H; Jin X; Zhang X; Zhao L; Lin B; Li L; Fei Z; Shen L; Fang Y; Pan H; Xie C
    J Transl Med; 2015 Mar; 13():104. PubMed ID: 25888911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast.
    Prasad CP; Rath G; Mathur S; Bhatnagar D; Parshad R; Ralhan R
    BMC Cancer; 2009 Sep; 9():325. PubMed ID: 19751508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p63-Mediated activation of the β-catenin/c-Myc signaling pathway stimulates esophageal squamous carcinoma cell invasion and metastasis.
    Lee KB; Ye S; Park MH; Park BH; Lee JS; Kim SM
    Cancer Lett; 2014 Oct; 353(1):124-32. PubMed ID: 25045846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical expression of beta-catenin, E-cadherin, cyclin D1 and c-myc in benign trichogenic tumors.
    Demirkan NC; Bir F; Erdem O; Düzcan E
    J Cutan Pathol; 2007 Jun; 34(6):467-73. PubMed ID: 17518774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NDRG1 overexpression promotes the progression of esophageal squamous cell carcinoma through modulating Wnt signaling pathway.
    Ai R; Sun Y; Guo Z; Wei W; Zhou L; Liu F; Hendricks DT; Xu Y; Zhao X
    Cancer Biol Ther; 2016 Sep; 17(9):943-54. PubMed ID: 27414086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multi-institutional study of immunohistochemical investigation for the roles of cyclin D1 and E-cadherin in superficial squamous cell carcinoma of the esophagus.
    Shiozaki H; Doki Y; Yamana H; Isono K
    J Surg Oncol; 2002 Mar; 79(3):166-73. PubMed ID: 11870667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of E-cadherin expression promotes migration ability of esophageal cancer cells.
    Li S; Qin X; Chai S; Qu C; Wang X; Zhang H
    Sci Rep; 2016 Feb; 6():21713. PubMed ID: 26898709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of TNFAIP2 suppresses proliferation and metastasis in esophageal squamous cell carcinoma through activation of the Wnt/β-catenin signaling pathway.
    Xie Y; Wang B
    Oncol Rep; 2017 May; 37(5):2920-2928. PubMed ID: 28393234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased expression of ARID1A contributes to infiltrative growth of esophageal squamous cell carcinoma.
    Ozawa Y; Nakamura Y; Fujishima F; Felizola SJ; Takeda K; Okamoto H; Ito K; Ishida H; Konno T; Kamei T; Ohuchi N; Sasano H
    Tohoku J Exp Med; 2015 Mar; 235(3):185-91. PubMed ID: 25757668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of e-cadherin and beta-catenin in human esophageal squamous cell carcinoma: relationships with prognosis.
    Zhao XJ; Li H; Chen H; Liu YX; Zhang LH; Liu SX; Feng QL
    World J Gastroenterol; 2003 Feb; 9(2):225-32. PubMed ID: 12532436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of the Wnt-β-catenin pathway in invasion and migration of oral squamous carcinoma cells.
    Iwai S; Yonekawa A; Harada C; Hamada M; Katagiri W; Nakazawa M; Yura Y
    Int J Oncol; 2010 Nov; 37(5):1095-103. PubMed ID: 20878057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-27a-3p Modulates the Wnt/β-Catenin Signaling Pathway to Promote Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1.
    Qiao B; He BX; Cai JH; Tao Q; King-Yin Lam A
    Sci Rep; 2017 Apr; 7():44688. PubMed ID: 28425477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability.
    Ortega P; Morán A; de Juan C; Frías C; Hernández S; López-Asenjo JA; Sánchez-Pernaute A; Torres A; Iniesta P; Benito M
    Clin Cancer Res; 2008 Feb; 14(4):995-1001. PubMed ID: 18281531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma.
    Sogabe Y; Suzuki H; Toyota M; Ogi K; Imai T; Nojima M; Sasaki Y; Hiratsuka H; Tokino T
    Int J Oncol; 2008 Jun; 32(6):1253-61. PubMed ID: 18497987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway.
    Ge XS; Ma HJ; Zheng XH; Ruan HL; Liao XY; Xue WQ; Chen YB; Zhang Y; Jia WH
    Cancer Sci; 2013 Dec; 104(12):1675-82. PubMed ID: 24118380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.
    Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH
    World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased expression of CDH1 or CTNNB1 affects poor prognosis of patients with esophageal cancer.
    Ishiguro H; Wakasugi T; Terashita Y; Sakamoto N; Tanaka T; Mizoguchi K; Sagawa H; Okubo T; Takeyama H
    World J Surg Oncol; 2016 Sep; 14(1):240. PubMed ID: 27600761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions.
    Nakanishi Y; Ochiai A; Akimoto S; Kato H; Watanabe H; Tachimori Y; Yamamoto S; Hirohashi S
    Oncology; 1997; 54(2):158-65. PubMed ID: 9075789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.